Literature DB >> 34213692

Overview of Albumin Physiology and its Role in Pediatric Diseases.

Charles B Chen1, Bilasan Hammo2, Jessica Barry3, Kadakkal Radhakrishnan3.   

Abstract

PURPOSE OF REVIEW: Albumin plays a critical role in a wide range of disease processes; however, the role of albumin in pediatric patients has not been well described. This article aims to review albumin physiology and kinetics in children, albumin's impact on pediatric diseases, and the utility of albumin as a predictor of clinical outcome. RECENT
FINDINGS: Hypoalbuminemia is seen in a wide range of conditions, including protein-losing enteropathy, hepatic synthetic failure, malnutrition, inflammatory states, and renal disease. While the impact of hypoalbuminemia has been more extensively studied in adult patients, there is a relative paucity of literature in the pediatric population. Hypoalbuminemia is a marker of poor outcome in critically ill children and those undergoing a wide range of medical interventions. Albumin infusions may be an effective therapy for fluid resuscitation and for patients with severe hypoalbuminemia.

Entities:  

Keywords:  Albumin; Critically ill; Gastrointestinal diseases; Malnutrition; Pediatrics; Protein-losing enteropathy

Year:  2021        PMID: 34213692     DOI: 10.1007/s11894-021-00813-6

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  69 in total

Review 1.  The role of albumin in critical illness.

Authors:  J P Nicholson; M R Wolmarans; G R Park
Journal:  Br J Anaesth       Date:  2000-10       Impact factor: 9.166

2.  Response of albumin synthesis to oral nutrients in young and elderly subjects.

Authors:  Giuseppe Caso; Joshua Feiner; Izolda Mileva; Leslie J Bryan; Patricia Kelly; Karen Autio; Marie C Gelato; Margaret A McNurlan
Journal:  Am J Clin Nutr       Date:  2007-02       Impact factor: 7.045

Review 3.  Clinical use of albumin.

Authors:  Paolo Caraceni; Manuel Tufoni; Maria Elena Bonavita
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

4.  Serum concentrations of 10 acute-phase proteins in healthy term and preterm infants from birth to age 6 months.

Authors:  F Kanakoudi; V Drossou; V Tzimouli; E Diamanti; T Konstantinidis; A Germenis; G Kremenopoulos
Journal:  Clin Chem       Date:  1995-04       Impact factor: 8.327

5.  Age and sex variation in serum albumin concentration: an observational study.

Authors:  Gary Weaving; Gifford F Batstone; Richard G Jones
Journal:  Ann Clin Biochem       Date:  2015-06-12       Impact factor: 2.057

6.  High affinity binding, endocytosis, and degradation of conformationally modified albumins. Potential role of gp30 and gp18 as novel scavenger receptors.

Authors:  J E Schnitzer; J Bravo
Journal:  J Biol Chem       Date:  1993-04-05       Impact factor: 5.157

7.  Ontogeny of plasma proteins, albumin and binding of diazepam, cyclosporine, and deltamethrin.

Authors:  Pankaj K Sethi; Catherine A White; Brian S Cummings; Ronald N Hines; Srinivasa Muralidhara; James V Bruckner
Journal:  Pediatr Res       Date:  2015-11-16       Impact factor: 3.756

8.  Insulin Is Required to Maintain Albumin Expression by Inhibiting Forkhead Box O1 Protein.

Authors:  Qing Chen; Mingjian Lu; Bobby R Monks; Morris J Birnbaum
Journal:  J Biol Chem       Date:  2015-12-14       Impact factor: 5.157

9.  Interstitial fluid colloid osmotic pressure in healthy children.

Authors:  Hans Jørgen Timm Guthe; Marianne Indrebø; Torbjørn Nedrebø; Gunnar Norgård; Helge Wiig; Ansgar Berg
Journal:  PLoS One       Date:  2015-04-08       Impact factor: 3.240

Review 10.  Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements.

Authors:  David G Levitt; Michael D Levitt
Journal:  Int J Gen Med       Date:  2016-07-15
View more
  1 in total

1.  Albumin Stimulates Epithelial Na+ Transport and Barrier Integrity by Activating the PI3K/AKT/SGK1 Pathway.

Authors:  Mandy Laube; Ulrich H Thome
Journal:  Int J Mol Sci       Date:  2022-08-08       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.